Literature DB >> 34550698

Preparation of Asymmetric Vesicles with Trapped CsCl Avoids Osmotic Imbalance, Non-Physiological External Solutions, and Minimizes Leakage.

Ming-Hao Li1, Daniel P Raleigh1,2,3, Erwin London1,2,4.   

Abstract

The natural asymmetry of cellular membranes influences their properties. In recent years, methodologies for preparing asymmetric vesicles have been developed that rely on cyclodextrin-catalyzed exchange of lipids between donor lipid multilamellar vesicles and acceptor lipid unilamellar vesicles, and the subsequent separation of the, now asymmetric, acceptor vesicles from the donors. Isolation is often accomplished by preloading acceptor vesicles with a high concentration of sucrose, typically 25% (w/w), and separating from donor and cyclodextrin by sucrose gradient centrifugation. We found that when the asymmetric vesicles prepared using methyl-α-cyclodextrin exchange were dispersed under hypotonic conditions using physiological salt solutions, there was enhanced leakage of an entrapped probe, 6-carboxyfluorescein. Studies with symmetric vesicles showed this was due to osmotic pressure and was specific to hypotonic solutions. Inclusion of cholesterol partly reduced leakage but did not completely eliminate it. To avoid having to use hypotonic conditions or to suspend vesicles at nonphysiological solute concentrations to minimize leakage, a method for preparing asymmetric vesicles using acceptor vesicle-entrapped CsCl at a physiological ion concentration (100 mM) was developed. Asymmetric vesicles prepared with the entrapped CsCl protocol were highly resistant to 6-carboxyfluorescein leakage out of the vesicles.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34550698      PMCID: PMC9128599          DOI: 10.1021/acs.langmuir.1c01971

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   4.331


  24 in total

Review 1.  Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences.

Authors:  Huan-Xiang Zhou; Germán Rivas; Allen P Minton
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

2.  The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy.

Authors:  A J Verkleij; R F Zwaal; B Roelofsen; P Comfurius; D Kastelijn; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1973-10-11

3.  Preparation and Drug Entrapment Properties of Asymmetric Liposomes Containing Cationic and Anionic Lipids.

Authors:  Bingchen Li; Erwin London
Journal:  Langmuir       Date:  2020-10-18       Impact factor: 3.882

4.  Efficient replacement of plasma membrane outer leaflet phospholipids and sphingolipids in cells with exogenous lipids.

Authors:  Guangtao Li; JiHyun Kim; Zhen Huang; Johnna R St Clair; Deborah A Brown; Erwin London
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

Review 5.  Effects of in vivo conditions on amyloid aggregation.

Authors:  Michael C Owen; David Gnutt; Mimi Gao; Sebastian K T S Wärmländer; Jüri Jarvet; Astrid Gräslund; Roland Winter; Simon Ebbinghaus; Birgit Strodel
Journal:  Chem Soc Rev       Date:  2019-07-15       Impact factor: 54.564

6.  The dependence of lipid asymmetry upon phosphatidylcholine acyl chain structure.

Authors:  Mijin Son; Erwin London
Journal:  J Lipid Res       Date:  2012-10-23       Impact factor: 5.922

7.  Engineering asymmetric vesicles.

Authors:  Sophie Pautot; Barbara J Frisken; D A Weitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

8.  The ratio of plasma membrane cholesterol to phospholipid and the inhibition of Sindbis virus maturation by low NaCl medium.

Authors:  R F Garry; D A Bostick; R Schram; M R Waite
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

9.  Macromolecular crowding as a suppressor of human IAPP fibril formation and cytotoxicity.

Authors:  Janine Seeliger; Alexander Werkmüller; Roland Winter
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.